We use cookies to give you the best experience and to help improve our website
Find out what cookies we use and how to disable them
Standards Development
This international standard specifies requirements and test methods for the design and performance of packaging systems used for transporting medical devices provided non-sterile to the point of use. Product designed and developed to be shipped non-sterile from the manufacturer is covered by the requirements in this document. It does not apply to packaging for terminally sterilized medical devices which are covered by ISO 11607-1/-2. It does not apply to packaging materials and/or systems used to contain a contaminated medical device during transportation of the item to the site of reprocessing or disposal. It does not apply to the maintenance of a certain microbiological state which would require integrity and microbial barrier properties.
In accordance with ISO TC122 strategic business plan, this proposed standard will provide cost effective and more reliable requirements allowing for clear, unambiguous technical specifications through harmonization and clarification. Regulatory authorities recognize the critical nature of packaging systems by considering them as an accessory or a component of a medical device. Medical device manufacturers have seen the value of ISO 11607-1 “Packaging for terminally sterilized medical devices - Part 1: Requirements for materials, sterile barrier systems and packaging systems” and have utilized this standard to demonstrate compliance to regulatory authorities and notified bodies. Until this time, a corresponding standard for non - sterile medical device packaging has not existed. Emulating the agreed upon framework of ISO 11607, this proposed standard will aid medical device manufacturers by providing a standard which may be used to support submissions to regulatory bodies including but not limited to: US Food & Drug Administration, Therapeutic Goods Administration of Australia, Brazil's Agência Nacional de Vigilância Sanitária, Health Canada, the Japanese Pharmaceuticals and Medical Devices Agency and the European Union General Safety and Performance Requirements under the MDR 2017/74.
You are now following this standard. Weekly digest emails will be sent to update you on the following activities:
You can manage your follow preferences from your Account. Please check your mailbox junk folder if you don't receive the weekly email.
You have successfully unsubscribed from weekly updates for this standard.
Comment on proposal
Required form fields are indicated by an asterisk (*) character.